SMAD4 and cancer: Since metastasis and recurrence were also correlated to cancer resistance, we also pooled the RRs (risk ratio) of metastasis and recurrence in SMAD4 subpopulation to evaluate the effect of SMAD4 expression loss on chemoresistance.